Medicina personalizada

en Salud

Blgo. Marco Galarza Perez

marcogalarzaperez@gmail.com
https://www.youtube.com/results?search_query=h
ow+to+read+the+genome+and+build+a+human+bei
ng+riccardo+sabatini
What is Personalized Medicine?
Scientific Advances Fuel Personalized Medicine
Personalized Medicine is a Multi-Faceted
Approach to Patient Care
Personalized Medicine Promises Improved Patient
Outcomes
Personalized Medicine Can Improve
Efficiencies within the Health Care System
Personalized Medicine Market Size, 2009 and 2015
What is a Biomarker?
A New Treatment Paradigm
 Molecular diagnosis and treatment stratification
for lung cancer

Following molecular
stratification a patient’s
tumour can now be classified
as either EGFR positive
(responsive to antibody
therapy) or ALK positive
(responsive to small molecule
therapy) , enabling them to
start treatment on the
therapy regime that will have
the most benefit to respond
to their specific genomic
variant.
 Why adopt a personalised medicine approach?

There is global recognition of the

potential benefits of personalised
medicine. Health systems
including the US, Germany,
France, Canada, Australia, China
and India are formulating policy
and research programmes to
support the adoption of more
personalised approaches to
healthcare.
Personalised medicine has
advantages for individual
patients, for populations, for the
NHS, for science and for the
wider economy.
Percentage of patients for whom drugs are
ineffective
Personalized Medicines Are Benefitting Patients
Across Many Different Diseases
Personalized Medicine Leads to Increased Survival
Rates: Chronic Leukemias
Personalized Medicine Yields Treatment
Breakthroughs: Metastatic Melanoma
Personalized Medicine Helps Predict Treatment
Response: Metastatic Colorectal Cancer
Personalized Medicine Enables Targeting of the
Underlying Cause of Disease: Cystic Fibrosis
The four ‘P’s of personalised medicine
Analysis of successful experiences at the international
level in Personalised, Precision, or Genomic Medicine
Conclusions of the analysis
of initiatives at the
international level
Common elements in
Personalised, Precision, or
Genomic Medicine strategies

The analysis of the actions carried

out within the different strategies
analyzed, identified the following
elements as necessary for the
development of Strategies at the
national level: